Kim YS, Jeon SH, Kim J, Koh JH, et al. A Double-Blind, Randomized, Placebo-Controlled, Phase II Clinical Study To Evaluate the Efficacy and Safety of Camostat Mesylate (DWJ1248) in Adult Patients with Mild to Moderate COVID-19. Antimicrob Agents Chemother 2023;67:e0045222.
PMID: 36515544